Two Sigma Investments, LP Instil Bio, Inc. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.63 $70,348 - $110,798	-175,871 Reduced 14.19%	1,063,249 $457,000
Q2 2023 Aug 14, 2023	BUY	$0.51 - $0.67 $42,583 - $55,942	83,497 Added 7.23%	1,239,120 $681,000
Q1 2023 May 15, 2023	SELL	$0.6 - $0.91 $12,357 - $18,742	-20,596 Reduced 1.75%	1,155,623 $762,000
Q4 2022 Feb 14, 2023	BUY	$0.48 - $5.33 $553,480 - $6.15 Million	1,153,084 Added 4984.15%	1,176,219 $741,000
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $458,862 - $727,271	-98,680 Reduced 81.01%	23,135 $112,000
Q2 2022 Aug 15, 2022	BUY	$4.21 - $11.15 $512,841 - $1.36 Million	121,815 New	121,815 $563,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.84B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.